# Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.

> **NCT00521365** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 88 (actual)

## Conditions studied

- Bipolar Disorder
- Bipolar Affective Psychosis
- Mania
- Manic Disorder
- Manic State

## Interventions

- **DRUG:** Quetiapine 600mg

## Key facts

- **NCT ID:** NCT00521365
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2012-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00521365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00521365, "Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00521365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*